A UK-based drugmaker has agreed to pay a record $1.4 billion settlement to the US government in order to end criminal and civil probes into allegations of illegal marketing of opioid addiction treatment medication, according to the Justice Department.
Suboxone, which “proved to be a blockbuster-selling drug for Indivior,” is supposedly an addiction-fighting medication that also contains opioids. How can you end your chemical addiction with another chemical, which in itself addictive, i.e. the opioid buprenorphine.
The settlement with Reckitt Benckiser Group (RB Group) will include multiple investigations into a subsidiary, Indivior (formerly Reckitt Benckiser Pharmaceuticals Inc.).
“Opioid withdrawal is difficult, painful, and sometimes dangerous; people struggling to overcome addiction face challenges that can often seem insurmountable,” said assistant Attorney General Jody Hunt of the DOJ’s Civil Division.
“Drug manufacturers marketing products to help opioid addicts are expected to do so honestly and responsibly.”
Suboxone, which proved to be a blockbuster-selling drug for Indivior, is an addiction-fighting medication that also contains opioids. Indivior was spun off into a separate company from the RB Group in December 2014, but the exposure and looming litigation and probes related to Suboxone were still attached to the parent company.
On April 9, a federal grand jury in Virginia indicted Indivior for “allegedly engaging in an illicit nationwide scheme to increase prescriptions of Suboxone,” according to the DOJ. The company denied the charges and trial is scheduled to start in May 2020.
Federal prosecutors charged that Indivior allegedly marketed a version of Suboxone (Suboxone Film) to medical professionals as less addictive and safer than other drugs containing its active ingredient, the opioid buprenorphine, according to the DOJ statement. –ABC News
According to the indictment, Indivior’s “Here to Help” web and phone resources actually funneled opioid-addicted patients to doctors who were actively prescribing Suboxone and other opioids “to more patients than allowed by federal law, at high doses, and in a careless and clinically unwarranted manner.”
The company was also accused of discontinuing its tablet form of Suboxone “based on supposed ‘concerns regarding pediatric exposure’ to tablets, despite Indivior executives’ knowledge that the primary reason for the discontinuance was to delay the Food and Drug Administration’s approval of generic tablet forms of the drug.”
That’s not even worthy of pursuing since no amount of chemical intoxication could eliminate the problem by which it is supposedly designed to contend with.
Included in the settlement is an immunity agreement, while RB Group will forfeit $647 million of proceeds from the sale of Indivior – nor will it manufacture, market or sell Schedule 1 – 3 controlled substances for three years.
That said, it’s not over for Invidior.
The trial against the RB Group’s former subsidiary Invidior is still slated to start next May. Thursday’s settlement was only with RB Group, and not Indivior.
In addition, the company also agreed to pay $700 million in civil settlements to the federal government and six states, as well as $50 million to the Federal Trade Commission.
RB issued a statement denying any wrongdoing.
“While RB acted lawfully at all times and expressly denies all allegations that it has engaged in any wrongful conduct, after careful consideration, the board of RB determined that the agreement is in the best interests of the company and its shareholders,” they said.
What we actually have here is the regulator doing its standard protocol of slapping the wrist of their own corporate client who may have forgotten to oil one of the most important cogs of the chemical industry.
The immunity agreement seals the deal of having to pay only a measly amount of what was earned from the product that doesn’t really cure addiction for good. The $1.4 billion fine can easily be entered as part of the regular cost of doing business, while the regulators get their periodic media mileage and more?
Based on the available 3-year data alone [2011-2013], Suboxone sales was at a whopping US$ 4,116,806,000.00!
In the meantime, the population is numbed, and the complications of using chemicals to mitigate pain and depression continue to be, well, depressing…
What is Suboxone?
Suboxone contains a combination of buprenorphine and naloxone. Buprenorphine is an opioid medication, sometimes called a narcotic. Naloxone blocks the effects of opioid medication, including pain relief or feelings of well-being that can lead to opioid abuse.
Suboxone is used to treat narcotic (opiate) addiction.
Suboxone is not for use as a pain medication.
This medicine can slow or stop your breathing, and may be habit-forming. MISUSE OF THIS MEDICINE CAN CAUSE ADDICTION, OVERDOSE, OR DEATH, especially in a child or other person using the medicine without a prescription.
Taking Suboxone during pregnancy may cause life-threatening withdrawal symptoms in the newborn.
Fatal side effects can occur if you use this medicine with alcohol, or with other drugs that cause drowsiness or slow your breathing.
Before taking this medicine
You should not use Suboxone if you are allergic to buprenorphine or naloxone (Narcan).
Tell your doctor if you have ever had:
- any type of breathing problem or lung disease;
- enlarged prostate, urination problems;
- liver or kidney disease;
- abnormal curvature of the spine that affects breathing;
- problems with your gallbladder, adrenal gland, or thyroid;
- a head injury, brain tumor, or seizures; or
- alcoholism, drug addiction, mental illness.
Some medicines can interact with buprenorphine and naloxone and cause a serious condition called serotonin syndrome. Be sure your doctor knows if you also take stimulant medicine, herbal products, or medicine for depression, mental illness, Parkinson’s disease, migraine headaches, serious infections, or prevention of nausea and vomiting. Ask your doctor before making any changes in how or when you take your medications.
If you use Suboxone while you are pregnant, your baby could become dependent on the drug. This can cause life-threatening withdrawal symptoms in the baby after it is born. Babies born dependent on habit-forming medicine may need medical treatment for several weeks. Tell your doctor if you are pregnant.
Buprenorphine and naloxone can pass into breast milk and may cause drowsiness or breathing problems in the nursing baby. Tell your doctor if you are breast-feeding.
Again, we ask, why take the risks of using chemicals to treat yourself of any malconditions when there are much safer methods to do it, e.g. hemp and cranial electrostimulation. Of course, if you want to prevent any complications with the regulators, the electronic option is always logical and most economical in the long term.Eliminate all forms of addiction, cure most ailments including cancer, and bypass the need for vaccinations with Virutron Antiviral + CES System and a good water ozonizer.